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Abstract
Background: A large number of patients have been suffer from breast cancer worldwide and this trend is increasing. It is difficult to de-
termine whether a lump is benign or malignant from clinical assessment; thus, the need for micropic and tissue analysis arises. Methods: 
This comparative retrospective cross sectional study was conducted in the Department of Pathology, Rehman Medical Institute, Peshawar, 
Pakistan from January 2006 to March 2013, to determine the value of fine needle aspiration cytology (FNAC) in the diagnosis of breast 
lump and to compare the result of FNAC with histological diagnosis to assess its accuracy. Results: Seventy-four  cases with breast lumps 
were presented for FNAC. Of these, 32.4% were reported as a C2 lesion, 4.1% were reported as benign with atypical cells (C3), 8.1% cases 
were suspicious for malignancy (C4), and 55.4% were positive for malignancy (C5). On histopathology examination, out of 24 cases which 
were reported as C2 lesions, 95.8% were benign and 4.1% turned out to be invasive ductal carcinoma. Of the cases that presented as C3 
lesions, one was diagnosed as benign duct ectasia, one with ductal carcinoma in situ, and one with invasive ductal carcinoma on histo-
pathological examination. The cases that were diagnosed as C4 lesions all turned out to be carcinoma on histopathology.  In this study, 
FNAC and histopathology diagnoses were strongly correlated [r 0.92, p <0.001]. Conclusion: Diagnosis of breast lump based on FNAC should 
be practiced as there is high correlation with histopathological finding. FNAC should be used as a routine diagnostic procedure due to its 
cost effectiveness, thus maximizing the availability of effective health care to patients with breast lesions.
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Introduction
Breast cancer is the most common cancer in women both in 
the developed and developing world. In 2012 it were diagnosed 
1.7 millions of cases worldwide and it is well-known that a half 
of cases and deaths occur in developing countries (Internatio-
nal Agency for Research on Cancer, IARC. Available from: http://
www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf, cited 
2014 Jun 20).1
Breast lumps are one of the most prevalent presenting com-
plaints in an outpatient department (OPD) in Pakistan.2 About 
90% are benign and of no grave consequences, but malignant 
lumps contribute to a consequential percentage of all breast 
lumps.2 With growing vigilance in the general population, espe-
cially about breast pathologies, and the associated solicitude 
and stress that this condition may lead to, the knowledge that 
breast cancer can have grim consequences compels patients 
to seek medical advice.3,4 It is difficult to determine whether 
a lump is benign or malignant from clinical assessment.5 A 
confident diagnosis can be established in more than 95% of 
cases utilizing triple assessment (examination, imaging and 
histological studies).6
Fine needle aspiration cytology (FNAC) is a relatively simple, 
reliable, atraumatic, economical and complication-free techni-
que for the evaluation of mass lesions. It can be facilely reite-
rated if an adequate aspirate is not obtained.4 FNAC is now a 
well-established technique for the investigation of women with 
suspected breast carcinoma.7
Fine-needle aspiration (FNA) has become one of the most im-
portant diagnostic tools for palpable breast masses and fal-
se-negative results have become a major concern. However, 
cytopathologists agree in certain parameters to the adequacy 
of an FNA specimen.8
It has been shown that FNAC has reduced the number of open 
biopsies because of its high diagnostic sensitivity and speci-
ficity. However, open biopsy is still preferred in some centers 
due to lack of expert cytologists.9 The biopsy of the palpable 
breast lesion predicated on the histological study of the tissue 
specimens can provide all the reliable information to the sur-
geon and oncologist for modern therapeutic strategies as part 
of the decision-making regarding the patient’s treatment. This 
technique permits the eventual use of neo-adjuvant therapy.10 
Different studies have determined that FNAC has a sensitivity 
ranging from 80% to 98% and a specificity of 99% to 100%.11
The purpose of the present study is to determine the value of 
fine needle aspiration cytology in the diagnosis of breast lumps 
and to compare the result of FNAC with histological diagnosis 
to assess its accuracy.
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Methods
This was a comparative cross-sectional study conducted at His-
topathology Department Rehman Medical Institute, Peshawar, 
Pakistan, from January 2006 to March 2013. Non-probability 
convenient sampling was used. The Ethical Review Board of Re-
hman Medical College, Peshawar, Pakistan approved the study. 
Attendants were informed of their right to refuse participation 
and of the respect of the confidentiality of their answers.
The guidelines of the Strengthening of the Reporting of Obser-
vational Studies in Epidemiology (STROBE) statement checklist 
for cross-sectional studies was followed in writing the present 
article.12 
All female patients with unknown primary diagnosis of breast 
lump undergoing FNAC followed by excision biopsy, were in-
cluded. Patients with recurrent malignancy, patients who un-
derwent FNAC but did not undergo subsequent histopathologi-
cal diagnosis, and patients under chemotherapeutic treatment 
were excluded from the study. The study included 74 cases.
FNA was performed utilizing a 5-millimeter (mL) or 1o mL dis-
posable syringe for each sample and for each patient. No local 
anesthetic was utilized. The needle was inserted into the pal-
pable lesions, either once or twice depending upon the size of 
the nodule. Cellular material was aspirated into a syringe and 
expelled onto slides. Three to four slides were prepared for 
each patient. A small or medium-sized drop of aspirate was put 
near the frosted edge of a slide that was placed on a table. A 
second slide was acclimated to spread the aspirated material 
in the same manner used to prepare a peripheral blood smear 
and one of the smears was wet fine-tuned in 95% methanol 
and stained with Hematoxylin and Eosin (H&E). The air dried 
smears were stained with Giemsa stain. The procedure was 
done within one hour, and the reports were signed-out within 
2 to 3 days.
The biopsy specimens were fine-tuned in 10% formalin for 24 
hours. Then gross examination was done in the Department 
of Pathology by consultant histopathologists. The gross and 
cut section findings were noted. Several bits were taken from 
opportune sites for processing and paraffin embedding. From 
each block, sections were cut at 4-5 microns thickness and 
stained with H&E.
Statistical analysis was performed using the Statistical Package 
for Social Science (SPSS©) version 20.13 Continuous data was 
displayed as the mean ± standard deviation (SD), while the 
categorical and nominal data was presented as frequencies and 
percentages. Pearson’s correlation was applied and a p-value 
of <0.05 was taken as statistically significant with a confidence 
level of 95%.
Results
The age range of the 74 patients included in this study was 15-
70 years with mean age of 41.43 ± 13.421. The most effected age 
group was 41-50 years. Out of these 25 cases were benign and 
49 were diagnosed as malignant. Highest frequencies of benign 
lesions were in the age group of 20-45 and the highest frequen-
cy of malignancy was in 30-55 year old women. The sensitivity 
of the test was 95.83% and specificity was 100%. Statistical 
Stage [n=74] Freq. (%) 
C2- Benign 24 (32.4)
  Fibro adenoma 9 (12.2)
  Fibrocystic 5 (6.8)
  Duct ectasia 4 (5.4)
  Proliferative breast lesion 3 (4.1)
  Lactating adenoma 2 (2.7)
  Pyogenic abscess 1 (1.4)
C3- benign with atypical cells 3 (4.1)
C4-suspecious for malignancy 6 (8.1)
C5-malignant 41 (55.4)
Table 1. Cytology Finding of Breast Lump on Fine Needle Aspiration (FNA)
Figure 1. Age Distribution of Patients with Benign and Malignant Breast 
Lump.
analysis by Chi-square test revealed a significant Chi-square 
value of 66.58 (P< 0.001) (Figure 1).
On cytology 24 patients (32.4%) had (C2) benign breast lesions. 
Out of these 24 cases, nine were reported as fibro-adenoma, 
five as fibrocystic disease, four as duct ectasia, three as pro-
liferative breast lesion, two as lactating adenoma and one as 
pyogenic abscess. Out of 74 patients, three cases (4.1%) were 
benign with atypical cells (C3), six cases (8.1%) were suspi-
cious for malignancy (C4), and 41 (55.4%) were positive for 
malignancy (C5) (Table 1). 
Out of a total of 74 cases that underwent a surgical procedure, 
24 were reported as benign lesions. Among these 24 cases, 
eight were reported as fibro adenoma, three were diagnosed 
as a phylliodes tumor, five as fibrocystic disease, six as duct 
ectasia and one had sub-acute mastitis along with duct ectasia. 
Among 24 cases one was reactive hyperplasia.
The remaining 50 cases were diagnosed as carcinoma of breast 
on histopathology. Among these, 39 were invasive ductal car-
cinoma, three with invasive lobar carcinoma, and two were 
diagnosed as infiltrating ductal carcinoma.
One case was of mixed invasive and mucinous carcinoma, one 
medullary carcinoma, one with ductal carcinoma with medu-
llary feature, one with malignant adnexal tumor, and one with 
border line stromal sarcoma. One was a case of in-situ ductal 
carcinoma. Out of these 39 cases with invasive ductal carcino-
ma, 21 of them were grade III, 17 grade II and only one was 
grade I. One case was reported as a C2 lesion (proliferative 
breast lesion) on biopsy and it was proved to be invasive duc-
tal carcinoma.
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Of the cases that were diagnosed as C3 lesions (benign with 
atypical cells), one was diagnosed as benign duct ectasia, one 
with ductal carcinoma in situ and one with invasive ductal 
carcinoma. All six cases diagnosed as C4 lesions (suspicious 
for malignancy) turned out to be malignant on histopathology. 
Out of these, five were invasive ductal carcinoma and one was 
borderline stromal sarcoma. The correlation between FNAC and 
histopathology is shown in table 2.
Discussion
Breast cancer is one of the most frequently occurring clinical 
conditions worldwide.14 Although there has been little success 
in controlling the disease, it is of general accord that a con-
fident preoperative diagnosis should be made before surgery, 
thus making FNAC a reliable diagnostic tool. It is a cheap and 
complication-free technique. The cost is economical, equip-
ment is low-priced and the technique is relatively easy.15 The 
procedure can also be performed anywhere. Furthermore, FNAC 
has a high accuracy, making it a reliable procedure.14 The ree-
sults can be obtained quickly and it is less invasive compared 
to tissue biopsy. 
FNAC is an easily diagnostic method for determining the causes 
of a breast lesion. Its success is due to its accuracy and cost 
effectiveness for a breast lump. Therefore, it has many advan-
tages for patients and physicians.16
In this study the sensitivity of the test was 95.83% and spe-
cificity was 100%. Statistical analysis by Chi-square test re-
vealed Chi-square value 66.58 (P< 0.001), which is statistically 
significant. In a similar study performed at Khyber Teaching 
Hospital, Peshawar, Pakistan, from August 2002 to May 2003 
the sensitivity and specificity of FNAC was 91.66% and 96.96%, 
respectively.3 the results of this study were similar to a study 
performed at the University Medical and Dental College, Faisa-
labad, Pakistan, from 2008 to 2011 which showed a sensitivity 
of 96.42%.1 Similarly, a study performed by Waqar describes the 
sensitivity of FNAC as almost 92.6%.17 In the literature, sensiti-
vity ranges from 94-99% and specificity reaches up to 100%.11,19
Keeping in mind the aim and objectives of the present study, 
71 of the 74 cases were diagnosed on FNAC as malignant 
and were correlated with their histological diagnosis. All the 
cytologically-diagnosed malignant lesions were proven to be 
malignant on histology. On FNAC, 24 were benign with one of 
the cases of benign breast lump turning out to be malignant 
on histological diagnosis. Fibro adenoma is a common benign 
breast lump in the majority of the young females.19 Three cases 
out of 74 on FNAC were C3 lesions (benign with atypical cells) 
on histological finding, with one turning out to be benign and 
two being malignant. Six cases were diagnosed as C4 lesions 
(suspicious for malignancy) on FNAC with all of them being 
malignant on histological examination. FNAC of the breast can 
reduce the number of open breast biopsies.8 The procedure has 
some challenges due false positives or uncertain test results in 
the diagnosis of fibrocystic disease, adenosis, epithelial hyper-
plasia with or without atypia, apocrine metaplasia, radial scar, 
and papilloma.20
The current study showed that FNAC is a reliable method. It 
helps in diagnosing breast lumps without surgical intervention 
and it also helps in pre-operative decision-making. From this 
study we can presume that FNAC has an association with his-
topathological findings and ought to be performed on standard 
premises. FNAC is also a good tool for follow up if there is recu-
rrence of breast lesions.  In the presence of budget constraints 
and personnel shortage, hospitals are required to demonstrate 
even great cost effectiveness in the diagnosis of breast lesions. 
Confident preoperative diagnosis is becoming increasingly im-
portant. FNAC should be practiced on routine basis as it is cost 
effective and reliable and thus maximizes the availability of 
health care for patients with breast-related pathologies.
There are some difficulties and limitations that need to be men-
tion about FNAC, first at all, both false-negative and false-posi-
tive results can occur.21 The most significant difficulty in making 
a diagnosis is the overlapping features of different lesions.22 
Other limitations to this procedure include, for example, that 
the lack of cellular pleomorphism can often give a false nega-
tive diagnosis. Our study was of a retrospective design where 
patients not undergoing an operation were not included. This 
suggests the possibility that false-negative cases may have 
been missed.
FNAC has certain limitations on accounts of inadequate sample 
and suspicious diagnoses. The overlapping of cytological featu-
res can cause cytodiagnostic errors and wrong diagnoses when 
the histological architecture from Inflammatory lesions mimics 
Malignancy.23
The normal surgical protocol in Pakistan is in which the biopsy 
is not proceded by FNA; the FNA has not been given its due 
importance in Pakistan. The protocol of doing a FNA before 
a biopsy has been established in a few pathology labs and 
hospitals. This study shows how much of a useful procedure 
FNA can be, perhaps reinforcing the paradigm shift in modern 
medicine where minimal invasive or non-invasive procedures 
are  beginning to replace invasive procedures.
Cases (%) FNAC Histopathology Finding
Benign (n=24) Malignant(n=50)
0 (0) C1-unsatisfactory 0 0
24 (32.4) C2-Benign 23 1
3 (4.1) C3-Benign with atypical cells 1 2
6 (8.1) C4-Suspecious for malignancy 0 6
41 (55.4) C5-malignant 0 41
Note: Fine needle aspiration cytology and histopathology diagnosis were strongly correlated, r(72) = 0.71, p < 0.001.
Table 2. Comparison of Fine Needle Aspiration Cytology (FNAC) and Histopathology Findings.
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